Sanofi Aktie

86,12EUR
-0,04EUR
-0,05%
27.10.2021
85,77EUR
+0,25EUR
+0,29%
27.10.2021

WKN: 920657 / ISIN: FR0000120578

  Kaufen  
Verkaufen
oder
Werbung

Sanofi Aktien News

03:35 Uhr
Merck strikes deal for global access to COVID-19 drug (Korea Times)
03:31 Uhr
GlaxoSmithKline plc (GSK) Q2 2021 Earnings Call Transcript (MotleyFool)
00:01 Uhr
Why Teva Pharmaceutical Industries Fell Today (MotleyFool)
27.10.21
Moderna (MRNA) Dips More Than Broader Markets: What You Should Know (Zacks)
27.10.21
News24.com | BioNTech to start building its African vaccine plant in mid-2022 (fin24)
27.10.21
Earnings Estimates Rising for Abbott (ABT): Will It Gain? (Zacks)
27.10.21
Novavax submits Covid jab for UK approval (Financial Times)
27.10.21
Why Novavax Stock Is Jumping Today (MotleyFool)
27.10.21
Merck greenlights generic manufacturing of its COVID pill (Deutsche Welle)
27.10.21
Will Pfizer (PFE) Keep the Earnings Streak Alive in Q3? (Zacks)
27.10.21
What’s Next For Novavax Stock After A Large 46% Fall In A Month? (Forbes)
27.10.21
Should You Buy Merck & Co. (MRK) Ahead of Earnings? (Zacks)
27.10.21
Novavax is seeking authorization in the U.K. for its COVID-19 vaccine (Market Watch)
27.10.21
Teva misses on both profit and revenue in Q3 (Globes)
27.10.21
Merck agrees to let other drug makers make its COVID pill (EN, Chinapost)
27.10.21
GlaxoSmithKline PLC : Director/PDMR Shareholding (Investegate)
27.10.21
Teva shares slump premarket after earnings fall short of estimates (Market Watch)
27.10.21
BioNTech to Report Third Quarter Financial Results and Operational Update on November 9, 2021 (rss)
27.10.21
What's Going On With Novavax Stock? (MotleyFool)
27.10.21
Merck signs royalty-free deal to expand access to its Covid-19 pill (Financial Times)
27.10.21
GlaxoSmithKline PLC : 3rd Quarter Results (Investegate)
27.10.21
BioNTech SE : BioNTech to Report Third Quarter Financial Results and Operational Update on November 9, 2021 (Investegate)
27.10.21
Coronavirus digest: FDA panel recommends BioNTech-Pfizer vaccine for children (Deutsche Welle)
27.10.21
FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years (rss)
27.10.21FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine in Children 5 to <12 Years (Businesswire)
27.10.21
Evotec announces first funded projects of translational BRIDGE beLAB1407 in collaboration with Bristol Myers Squibb (EN, Evotec)
26.10.21
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know (Zacks)
26.10.21
BioNTech SE Sponsored ADR (BNTX) Stock Sinks As Market Gains: What You Should Know (Zacks)
26.10.21
: FDA advisors recommend BioNTech and Pfizer’s COVID-19 shot for children (MarketWatch)
26.10.21
Pfizer (PFE) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
26.10.21
Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for (Zacks)
26.10.21
Novartis (NVS) Q3 2021 Earnings Call Transcript (MotleyFool)
26.10.21
Johnson & Johnson Statement on Texas Opioid Settlement Agreement (EN, Johnson & Johnson)
26.10.21
BioNTech to work with Senegal, Rwanda to make mRNA vaccines (EN, Chinapost)
26.10.21
Has Abbott Laboratories (ABT) Outpaced Other Medical Stocks This Year? (Zacks)
26.10.21
Novavax Hasn’t Delivered A Vaccine Yet, But The Stock May Be Worth A Look (Forbes)
26.10.21
Novartis (NVS) Q3 Earnings Beat, Sandoz Under Strategic Review (Zacks)
26.10.21
BioNTech to open Africa’s first mRNA manufacturing plant (Financial Times)
26.10.21
Moderna to supply African Union with up to 110 million doses over the next year (Market Watch)
26.10.21
BioNTech to build mRNA manufacturing facility in the African Union (Market Watch)
Seite: 123456789...25

Sanofi News

Sanofi News: auf dieser Seite finden Sie alle Sanofi News und Nachrichten zur Sanofi Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sanofi News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sanofi News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung
finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln